SUVENNSESuven Life Sciences Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 8 Jul · 17:27 IST

RTA certificate on demat and remat filings for June 2026 quarter

SUVEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+12.1%1-day move
₹318.00
prior close
₹320.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+1.5+1.6+2.0+12.1+12.9+9.7+12.4+7.2+6.3
Up moveDown movePending
AI summary

Suven Life Sciences submitted a routine compliance certificate from its registrar Kfin Technologies for the quarter ended June 30, 2026. Under SEBI Depositories Regulations 2018, the RTA confirms that details of shares dematerialized and rematerialized during the quarter have been shared with BSE and NSE. This is a standard quarterly regulatory filing with no business or financial substance.

Likely market impact

Routine compliance filing, no material impact on shareholders or stock price